Next Gen pairs a peer physician education community with a compliant supply network — so licensed practitioners can bring regenerative biologics, peptides, and integrated therapeutics into their practice, with the training and sourcing to back it up.
Every practitioner comes in through the community — informed first. From there, branch into the path that fits: source for your clinic, or represent to the clinics you know. See the journeys →
The front door. Peer-led education, clinical protocols, and a network of practitioners — informed first, before sourcing supply or representing. Founding access is limited.
Join the community →Source compliant regenerative tissue allografts under a practitioner supply agreement — with real-time tracking and same-day / next-day fulfillment.
Join the doctor waitlist →Represent a compliant, science-grounded supply to the clinics you already know. Independent 1099, commission-based, with resources and real-time attribution.
Join the rep waitlist →Most practitioners hit two walls at once: no compliant training path, and no supplier they trust. Next Gen closes both.
A peer-driven education and training network for physicians entering regenerative medicine — led by a practicing clinician, not a vendor.
A practitioner-facing supply network — regenerative biologics plus peptides, exosomes, supplements, kits and clinical devices — sourced through vetted labs and manufacturers, with regulatory transparency and consistent supply as the differentiators.
Founder & Medical Director · Next Gen
A practicing chiropractic physician and CE-approved regenerative-medicine educator who built the community and the supply network because the industry needed both.
Dr. Funderlich built Next Gen's practitioner supply — sourcing regenerative biologics, peptides, and clinical therapeutics through vetted labs and manufacturers — and teaches regenerative-medicine and orthobiologic protocols to physicians across the country as a CE-approved educator.
The result is a rare alignment for practitioners: the person setting the standard is the same person supplying the biologics and teaching the clinical protocols.
Co-founder & Head of Growth · Next Gen
The growth and technology partner behind Next Gen — owner of RBV Media, an AI-powered marketing agency, and the architect of the systems that put Next Gen's supply, education, and ordering in front of the right practitioners.
Christopher owns and runs RBV Media, where he's run paid acquisition for brands across real estate, health, aesthetics, and e-commerce, and helped generate multiple six figures in sales for the businesses he works with — from first customer to scaled acquisition.
As Next Gen's Chief AI Architect and Engineer, he designs and builds the software behind the operation — full-stack apps, marketing automation, and AI agents that run acquisition, ordering, and support end-to-end. A self-made operator who built the craft from the ground up, now aimed at getting compliant regenerative medicine in front of the practitioners who want it.
Regenerative biologics — plus peptides, exosomes, supplements, kits and clinical devices — sourced for licensed clinician use only. Not for direct consumer sale. Formats and pricing are confirmed behind supply access.
Umbilical cord–derived Wharton's Jelly connective-tissue allograft — preservative-free, minimally manipulated, for homologous use, with sourcing and processing documentation.
Preservative-free chorionic tissue allograft — supplied with the consistency and documentation practitioners need to source with confidence.
Preservative-free amniotic membrane allograft, prepared for integration into regenerative clinical protocols.
Next Gen sources across vetted labs and manufacturers — so your clinic buys biologics, peptides, and the rest of the regenerative toolkit from one compliant supply partner, not five vendors.
Tell us where you fit and a member of the Next Gen team will follow up. Founding-community and supply-agreement access are practitioner-qualified.